Head-to-head · free

Lumexa Imaging vs 908 Devices Inc.

LMRI vs MASS — return on capital, cash generation, margins and balance sheet side by side.

LMRI

1 / 3

measures where LMRI leads

MASS

2 / 3

measures where MASS leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureLMRIMASS · FY2025
Revenue—$56.2M
Net income—$19.5M
Revenue growth (yearly, multi-year)—7.4%
Free cash flow—(24.6M)
Free cash flow margin—-43.9%
Net cash / (debt)——
ROIC——
Return on equity-12.6%15.1%
Gross margin15.4%50.6%
Operating margin2.6%-45.7%
Net debt / EBITDA5.06x—

Figures are as reported by each company; latest fiscal year shown.

Where Lumexa Imaging's cash went

Not reported yet.

Full LMRI profile →

Where 908 Devices Inc.'s cash went (FY2025)

Capital spending
$955000
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full MASS profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons